Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Krystal Biotech (KRYS) Return on Assets: 2021-2025

Historic Return on Assets for Krystal Biotech (KRYS) over the last 4 years, with Sep 2025 value amounting to 0.17%.

  • Krystal Biotech's Return on Assets rose 11.00% to 0.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17%, marking a year-over-year increase of 11.00%. This contributed to the annual value of 0.10% for FY2024, which is 8.00% up from last year.
  • Per Krystal Biotech's latest filing, its Return on Assets stood at 0.17% for Q3 2025, which was up 26.13% from 0.13% recorded in Q2 2025.
  • In the past 5 years, Krystal Biotech's Return on Assets ranged from a high of 0.17% in Q3 2025 and a low of -0.25% during Q2 2023.
  • Its 3-year average for Return on Assets is 0.02%, with a median of 0.06% in 2024.
  • Per our database at Business Quant, Krystal Biotech's Return on Assets dropped by 12bps in 2022 and then surged by 37bps in 2024.
  • Krystal Biotech's Return on Assets (Quarterly) stood at -0.13% in 2021, then declined by 12bps to -0.25% in 2022, then climbed by 25bps to -0.00% in 2023, then climbed by 9bps to 0.09% in 2024, then rose by 11bps to 0.17% in 2025.
  • Its last three reported values are 0.17% in Q3 2025, 0.13% for Q2 2025, and 0.12% during Q1 2025.